Management of malaria in Thailand

  • Silachamroon, Udomsak (Hospital for Tropical Diseases, Faculty of Tropical Medicine, Mahidol University) ;
  • Krudsood, Srivicha (Hospital for Tropical Diseases, Faculty of Tropical Medicine, Mahidol University) ;
  • Phophak, Nanthaphorn (Hospital for Tropical Diseases, Faculty of Tropical Medicine, Mahidol University) ;
  • Looareesuwan, Sornchai (Hospital for Tropical Diseases, Faculty of Tropical Medicine, Mahidol University)
  • Published : 2002.03.01

Abstract

The purpose of treatment for uncomplicated malaria is to produce a radical cute using the combination of: artesunate (4 mg/kg/day) plus mefloquine (8 mg/kg/day) for 3 days; a fixed dose of artemether and lumefantrine (20/120 mg tablet) named $Coartem^{\circledR}$ (4 tablets twice a day for three days for adults weighing more than 35 kg); quinine 10 mg/kg 8-hourly plus tetracycline 250 mg 6-hourly for 7 days (or doxycycline 200 mg as an alternative to tetracycline once a day for 7 days) in patients aged 8 years and over; $Malarone^{\circledR}$ (in adult 4 tablets daily for 3 days). In treating severe malaria, early diagnosis and treatment with a potent antimalarial drug is recommended to save the patient's life. The antimalarial drugs of choice are: intravenous quinine or a parenteral form of an artemisinin derivative (artesunate i.v./i.m. for 2.4 mg/kg followed by 1.2 mg/kg injection at 12 and 24 hr and then daily for 5 days; artemether i.m. 3.2 mg/kg injection followed by 1.6 mg/kg at 12 and 24 hrs and then dialy for 5 days; arteether i. m. ($Artemotil^{\circledR}$) with the same dose of artemether or artesunate suppository (5 mg/kg) given rectally 12 hourly for 3 days. Oral arlemisinin derivatives (artesunate, artemether, and dihydroartemisinin with 4 mg/kg/day) could replace parenteral forms when patients can tolerate oral medication. Oral mefloquine (25 mg/kg divided into two doses 8 hrs apart) should be given at the end of the artemisinin treatment course to reduce recrudescence.

Keywords

References

  1. Bunnag D, Karbwan J, Harinasuta T (1992) Artemether in the treatment of multiple drug resistant falciparum malaria. Southeast Asian J Trop Med Public Health 23: 762-768
  2. Looareesuwan S, Harinasuta T, Chongsuphajaisiddhi T (1992b) Drug resistant malaria with special reference to Thailand. Southeast Asian J Trop Med Public Health 12: 621-634
  3. Looareesuwan S, Kyle DE, Viravan C, Vanijanonta S, Wilairatana P, Wernsdorfer WH (1996b) Clinical study of pyronaridine for the treatment of acute uncomplicated falciparum malaria in Thailand. Am J Trop Med Hyg 54: 205-209
  4. Looareesuwan S, Olliaro P, White NJ, et al. (1998a) Consensus recommendation on the treatment of malaria in Southeast Asia. Southeast Asian J Trop Med Public Health 29: 355-360
  5. Looareesuwan S, Schilizzi BM, Oosterhuis B, et al. (2002) Dose-fining and efficacy study for i.m. artemotil (beta-arteether) and comparison with i.m. artemether in acute uncomplicated P. falciparum malaria. Brit J Clin Pharm (in press)
  6. Looareesuwan S, Vanijanonta S, Viravan C, et al. (1994a) Randomised trial of mefloquinetetracycline, and quinine-tetracycline for acute uncomplicated falciparum malaria. Acta Tropica 57: 47-53
  7. Looareesuwan S, Viravan C, Vanijanonta S, et al. (1994b) Randomised trial of mefloquinedoxycycline, and artesunate-doxycycline for treatment of acute uncomplicated falciparum malaria. Am J Trop Med Hyg 50: 784-789
  8. Looareesuwan S, Viravan C, Vanijanonta S, et al. (1992a) Randomised trials of artesunate and mefloquine alone and in sequence for acute uncomplicated falciparum malaria. Lancet 339: 821-824
  9. Looareesuwan S, Wilairatana P, Chalermrut K, Rattanapong Y, Canfield C, Hutchinson DBA (1999a) Efficacy and safety of atovaquone/proguanil compared with mefloquine for treatment of acute Plasmodium falciparum malaria in Thailand. Am J Trop Med Hyg 60: 526-532
  10. Looareesuwan S, Wilairatana P, Chokejindachai W, et al. (1999c) A randomised, double-blind, comparative trial of a new oral combination of artemether and benflumetol (CGP 56697) with mefloquine in the treatment of acute Plasmodium falciparum malaria in Thailand. Am J Trop Med Hyg 60: 238-243
  11. Looareesuwan S, Wilairatana P, Chokejindachai W, Viriyavejakul P, Krudsood S, Singhasivanon P (1998b) Research on new antimalarial drugs and the use of drugs in combination at the Bangkok Hospital for Tropical Diseases. Southeast Asian J Trop Med Public Health 29: 344-354
  12. Looareesuwan S, Wilairatana P, Glanarongran R, et al. (1999b) Atovaquone and proguanil hydrochloride followed by primaquine for treatment of Plasmodium vivax malaria in Thailand. Trans R Soc Trop Med Hyg 93: 637-640
  13. Looareesuwan S, Wilairatana P, Molunto W, Chalermrut K, Olliaro P, Andrial M (1997c) A comparative clinical trial of sequential treatments of severe malaria with artesunate suppository followed by mefloquine in Thailand. Am J Trop Med Hyg 57: 348-353
  14. Looareesuwan S, Wilairatana P, Vanijanonta S, Pitisuttithum P, Rattanapong Y, Andrial M (1997b) Monotherapy with artesunate for uncomplicated falciparum malaria: A comparison of 5-day and 7-day regimens. Acta Tropica 67: 197-205
  15. Looareesuwan S, Wilairatana P, Vanijanonta S, Pitisuttithum P, Viravan C, Kraisintu K (1996a) Treatment of acute uncomplicated falciparum malaria with oral dihydroartemisinin. Ann Trop Med Parasitol 90: 21-28
  16. Looareesuwan S, Wilairatana P, Vanijanonta S, Viravan C, Andrial M (1995) Efficacy and tolerability of a sequential, artesunate suppository plus mefloquine, treatment of severe falciparum malaria. Ann Trop Med Parasitol 89: 469-475
  17. Looareesuwan S, Wilairatana P, Viravan C, Vanijanonta S, Pitisuttithum P, Kyle DE (1997a) Open randomised trial of oral artemether alone and sequential combination with mefloquine for acute uncomplicated falciparum malaria. Am J Trop Med Hyg 56: 613-617
  18. Newton P, White NJ (1999) Malaria: New developments in treatment and prevention. Ann Rev Med 50: 179-192
  19. van Vugt M, Wilairatana P, Gemperli B, et al. (1999) Efficacy of six doses of artemetherlumefantrine (benflumetol) in multidrugresistant Plasmodium falciparum malaria. Am J Trop Med Hyg 60: 936-942
  20. Walsh DS, Looareesuwan S, Wilairatana P, et al. (1999) Randomized dose-ranging study of the safety and efficacy of WR 238605 (Tafenoquine) in the prevention of relapse of Plasmodium vivax malaria in Thailand. JID 180: 1282-1287
  21. WHO (2000) Severe falciparum malaria. Trans R Soc Trop Med Hyg 94(suppl 1): 1-90
  22. Wilairatana P, Chantavanich P, Singhasivanon P, et al. (1998) A clinical trial of dihydroartemisinin for the treatment of acute uncomplicated falciparum malaria in Thailand: a comparison of three different formulations. Int J Parasitol 28: 1213-1218
  23. Wilairatana P, Krudsood S, Silachamroon U, et al. (2000) Clinical trial of sequential treatments of moderately severe and severe malaria with dihydroartemisinin suppository followed by mefloquine in Thailand. Am J Trop Med Hyg 63: 290-294
  24. Wilairatana P, Viriyavejakul P, Looareesuwan S, Chongsuphajaisiddhi T (1997) Artesunate suppositories: an effective treatment for severe falciparum malaria in rural areas. Ann Trop Med Parasitol 91: 891-896